GlassScriptPhysician profile
John B Ortolani
NPI 1760781330
$3,767.51
in general payments reported to CMS, 2019-2025
20 companies · $403 in 2025
The $403 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.56 · 2020: $238 · 2021: $371 · 2022: $712 · 2023: $1,010 · 2024: $981 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,393.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $465.99 | 2020-2024 | Stratafix, Echelon Circular, Echelon Flex |
| Integra Lifesciences Corporation | $387.60 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Thd America, INC. | $366.47 | 2021-2025 | |
| Fujifilm Healthcare Americas Corporation | $355.43 | 2023-2024 | Fujifilm |
| Medtronic, INC. | $331.31 | 2023-2024 | Progrip, Sonicision, Signia |
| Exact Sciences Corporation | $307.56 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Axonics, INC. | $288.32 | 2020-2024 | Axonics |
| Boston Scientific Corporation | $195.95 | 2022-2025 | General - Hemostasis |
| Tela Bio, INC. | $151.46 | 2022 | |
| Pentax of America, INC. | $138.46 | 2023 | Inspira |
| Activ Surgical, INC. | $126.33 | 2023 | Activsight |
| Smith+Nephew, INC. | $124.99 | 2022 | |
| Janssen Biotech, INC. | $105.02 | 2021-2023 | Stelara |
| Sanara Medtech INC. | $104.89 | 2024 | Celleraterx |
| Intuitive Surgical, INC. | $99.62 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $88.29 | 2023 | Sensura Mio |
| Medrobotics INC. | $53.56 | 2019 | |
| Hollister Incorporated | $30.02 | 2022 | |
| Solventum Corporation | $26.07 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Stryker Corporation | $20.17 | 2024 | Aim (Advanced Imaging Modality) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ortolani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.